| Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
| 2025 | Reply to P. de Boissieu et al | Spigel, David R; ...; Chen, Yuanbin; Navarro, Alejandro; Chih, Hsin Yang James; Stojanovic, Goran; Jove, Maria; ...; Andric, Zoran G   ; ...;
(broj, koautora 17);
| Информативни прилог | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
| 2025 | Long-term results of a randomized controlled trial of biosimilar CT-P16 and reference bevacizumab in patients with metastatic or recurrent non-small cell lung cancer | Andric, Zoran ; ...; (broj, koautora 16) | Научни чланак | 22M22 - Међународни часопис категорије M22 |
| 2025 | Real-world treatment patterns in patients with human epidermal growth factor receptor 2 (HER2) - positive early breast cancer in Serbia and Montenegro - HEReNA | Bozovic-Spasojevic, I; Milovic-Kovacevic, M ; Lekic, S; Cvetanovic, A; Kolarov-Bjelobrk, Ivana ; Lucic, J; Andric, Z ; Milenkovic, D; ...; Vukovic, I;
Petronijevic, M; Calamac, M; Djurmez, O; Djuric, S ; Perduv, V; Radisavljevic, M; Popovic, Lazar ; | Конференцијски рад | |
| 2024 | Whole exome sequencing (WES) analyses from IMpower133 and 6-year (y) overall survival (OS) from IMbrella A in patients (pts) with extensive-stage small cell lung cancer (ESSCLC) treated with atezolizumab (atezo) | Kao, SCH; Reck, M; Liu, SV; Dziadziuszko, R; Hochmair, MJ; Huemer, F; Gilberto, de Castro J; Bernabe, Caro R; Kim, SH; Kowalski, DM;
Andric, Zoran G ; Oancea, M; Kaul, M; Li, H; Danner, B; Lee, MC; Nabet, BY; Sugawara, S; | Конференцијски рад | |
| 2024 | Pneumologische Onkologie Tumor Treating Fields (TTFields) therapy with standard systemic therapy in metastatic non-small cell lung cancer following progression on or after platinum-based therapy: global randomized, pivotal (phase 3) LUNAR study | Weiss, L; ...; Andric, Zoran G ; ...; (broj, koautora 26) | Конференцијски рад | |
| 2024 | Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON) | Tobias, Joshua; ...; Andric, Zoran G ; ...; Nikolic, Ivan ; Petrovic, Zoran; ...; (broj, koautora 17) | Научни чланак | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
| 2024 | Tumor Treating Fields (TTFields) therapy with standard systemic therapy in metastatic non-small cell lung cancer following progression on or after platinum-based therapy: global, randomized, pivotal (phase 3) LUNAR study | Greil, Richard; ...; Andric, Zoran ; ...; (broj, koautora 25) | Конференцијски рад | |
| 2024 | 3-year follow-up of a phase III study to compare efficacy and safety of a bevacizumab biosimilar, CT-P16, and reference bevacizumab as first-line treatment for metastatic or recurrent non-squamous non-small cell lung cancer | Verschraegen, C; Andric, Zoran G ; Moiseenko, FV; Makharadze, T; Oleksiienko, A; Ruiz, EP Yanez; Kim, SH; Ahn, K; Park, TH; Ju, HA;
Baek, EH; Kwon, S; Lee, SJ; Chang, I; Kim, SH; Kim, HA; Lee, E; Ohe, Y;
| Конференцијски рад | |
| 2024 | Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial | Reck, Martin; ...; Andric, Zoran G ; ...; (broj, koautora 18) | Научни чланак | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
| 2024 | Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study | Reck, Martin; ...; Andric, Zoran G ; ...; (broj, koautora 24) | Научни чланак | 21M21 - Водећи међународни часопис категорије M21 |
| 2024 | Tumor Treating Fields (TTFields) Therapy with Standard of Care in Metastatic Non-small Cell Lung Cancer Following Progression on or after Platinum Therapy: Global, Randomized, Pivotal Phase 3 LUNAR Study | Leal, Ticiana A; ...; Andric, Zoran G ; ...; (broj, koautora 20) | Конференцијски рад | |
| 2024 | RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer | Spigel, David R; ...; Stojanovic, Goran; ...; Andric, Zoran G ; ...; (broj, koautora 17) | Научни чланак | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
| 2024 | Final results of the phase II trial of HER-Vaxx, a B-cell peptide-based vaccine plus standard care of chemotherapy in patients with HER2-overexpressing advanced gastric cancer - (HERIZON) | Tobias, Joshua; ...; Andric, Zoran G ; Petrovic, Z; Nikolic, Ivan V ; ...; (broj, koautora 17) | Конференцијски рад | |
| 2023 | HERIZON: A phase II study of HER-Vaxx (IMU-131), a HER2targeting peptide vaccine plus standard of care chemotherapy in patients with HER2+advanced stomach cancer - Dose-dependent anti-cancer antibodies correlating with improved clinical outcome | Tobias, Joshua; Kundi, Michael; Garner-Spitzer, E; Zielinski, Christoph; Maglakelidze, Marina; Andric, Zoran G ; Petrovic, Z; Nagarkar, R; Chawla, T; Chong, LO;
Nixon, B; Yavrom, S; Ede, NJ; Wiedermann, Ursula;
| Конференцијски рад | |
| 2023 | Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study | Leal, Ticiana A; ...; Andric, Zoran G ; ...; (broj, koautora 25) | Научни чланак | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
| 2023 | RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC) | Rudin, CM; Dowlati, A; Chen, Y; Navarro, Mendivil AF; Yang, JC-H; Stojanovic, Goran; Rich, P; Andric, Zoran G ; Wu, Y-L; Chen, H;
Zhang, L; Yeung, S; Benzaghou, FM; Paz-Ares, L; Bunn, PA;
| Конференцијски рад | |
| 2023 | HERIZON: A phase 2 study of HER-Vaxx (IMU-131), a HER2t-argeting peptide vaccine plus SOC chemotherapy in patients with HER2+advanced stomach cancer - correlation of the antibody responses and clinical outcome | Tobias, Joshua; Kundi, Michael; Garner-Spitzer, E; Zielinski, Christoph; Maglakelidze, Marina; Andric, Zoran G ; Petrovic, Zeljko M; Nagarkar, R; Chawla, T; Chong, LMO;
Nixon, B; Yavrom, S; Ede, NJ; Wiedermann, Ursula;
| Конференцијски рад | |
| 2023 | Impact of TTFields therapy on global and functional health-related quality of life (HRQoL) in metastatic non-small cell lung cancer (mNSCLC) from the pivotal LUNAR study | Kotecha, R; ...; Andric, Zoran G ; ...; (broj, koautora 20) | Конференцијски рад | |
| 2023 | Tumor Treating Field (TTFields) therapy with standard of care (SOC) in metastatic non-small cell lung cancer (mNSCLC) following platinum failure: Randomized, phase 3 LUNAR study | Leal, Ticiana; ...; Andric, Zoran G ; ...; (broj, koautora 20) | Конференцијски рад | |
| 2023 | Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC | Andric, Zoran G ; ...; Stojanovic, Goran; Petrovic, Marina D ; ...; (broj, koautora 21) | Научни чланак | 21M21 - Водећи међународни часопис категорије M21 |